Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Brain, Kate E ^a   Smits, Stephanie ^a   Simon, Alice E ^b,c   Forbes, Lindsay J ^d   Roberts, Chris ^e   Robbé, Iain J ^f   Steward, John ^g   White, Ceri ^g   Neal, Richard D ^h   Hanson, Jane ⁱ  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CITY UNIVERSITY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e WELSH GOVERNMENT   (United Kingdom)

^f MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^g Welsh Cancer Intelligence and Surveillance Unit   (United Kingdom)

^h BANGOR UNIVERSITY   (United Kingdom)

ⁱ Welsh Cancer National Specialist Advisory Group   (United Kingdom)

Author keywords

Anticipated delay; Awareness; Ovarian cancer; Symptoms

Indexed keywords

ABDOMINAL PAIN; ADULT; AGE; AGED; ANTICIPATED DELAY; ARTICLE; BLADDER FUNCTION; DEFECATION HABIT; DELAYED DIAGNOSIS; EATING DISORDER; EDUCATIONAL STATUS; EMOTION; FEMALE; HEALTH BEHAVIOR; HEALTH BELIEF; HUMAN; OVARY CANCER; PATIENT WORRY; PELVIC PAIN; PERSONAL EXPERIENCE; POSTMENOPAUSE BLEEDING; RANDOM SAMPLE; SINGLE WOMAN; SYMPTOM; SYMPTOM AWARENESS;

AGED; ANIMALS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; OVARIAN NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; POSTMENOPAUSE; QUESTIONNAIRES; RISK FACTORS; WALES;

EID: 84897520708     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-171     Document Type: Article

References (51)

1. Cancer research UK ovarian cancer UK statistics. [http://publications.cancerresearchuk.org/downloads/Product/cs_pdf_ovarian_march_2011.pdf].
2. Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L, Mosgaard BJ, Nordin A, Rosen B, Engholm G, Gjerstorff ML, Hatcher J, Johannesen TB, McGahan CE, Meechan D, Middleton R, Tracey E, Turner D, Richards MA, Rachet B, . ICBP Module 1 Working Group Stage at diagnosis and ovarian cancer survival: evidence from the international cancer benchmarking partnership. Gynecol Oncol 2012, 127:75-82. 10.1016/j.ygyno.2012.06.033, 22750127, ICBP Module 1 Working Group.
3. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999, 353:1119-1126. 10.1016/S0140-6736(99)02143-1, 10209974.
4. Wardle J, Waller J, Brunswick N, Jarvis MJ. Awareness of risk factors for cancer among British adults. Public Health 2001, 115:173-174. 10.1038/sj.ph.1900752, 11429711.
5. Robb K, Stubbings S, Ramirez A, Macleod U, Austoker J, Waller J, Hiom S, Wardle J. Public awareness of cancer in Britain: a population-based survey of adults. Brit J Cancer 2009, 101:18-123.
6. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA, . ICBP Module 1 Working Group Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the international cancer benchmarking partnership): an analysis of population-based cancer registry data. Lancet 2011, 377:127-138. 10.1016/S0140-6736(10)62231-3, 3018568, 21183212, ICBP Module 1 Working Group.
7. Bankhead C, Collins C, Stokes-Lampard H, Rose P, Wilson S, Clements A, Mant D, Kehoe S, Austoker J. Identifying symptoms of ovarian cancer: a qualitative and quantitative study. Brit J Obs Gyn 2008, 115:1008-1014.
8. Hamilton W, Peters TJ, Bankhead C, Sharp D. Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ 2009, 339:b2998. doi:10.1136/bmj.b2998, 10.1136/bmj.b2998, 2731836, 19706933.
9. Goff BA, Mandel L, Muntz HG, Melancon CH. Ovarian carcinoma diagnosis: results of a national ovarian cancer survey. Cancer 2000, 89:2068-2075. 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z, 11066047.
10. Smith EM, Anderson B. The effects of symptoms and delay in seeking diagnosis on stage of disease at diagnosis among women with cancers of the ovary. Cancer 1985, 56:2727-2732. 10.1002/1097-0142(19851201)56:11<2727::AID-CNCR2820561138>3.0.CO;2-8, 4052947.
11. Department of Health key messages for ovarian cancer for health professionals. [http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_110534].
12. National Institute for Health and Clinical Excellence (NICE) guidance Ovarian Cancer: The Recognition and Initial Management of Ovarian Cancer 2011, Cardiff: National Collaborating Centre for Cancer, National Institute for Health and Clinical Excellence (NICE) guidance.
13. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007, 335:136. 10.1136/bmj.39261.471806.55, 1925200, 17615182.
14. Cancer Facts & Figures 2011, Atlanta: American Cancer Society, [http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-029771.pdf].
15. Department of Health key messages for ovarian cancer for members of the public. [http://www.eveappeal.org.uk/media/42340/km_ovarian.pdf].
16. Richards MA. The national awareness and early detection initiative: size of the prize for earlier diagnosis of cancer in England. Brit J Cancer 2009, 101:S125-S129. 2790715, 19956156.
17. National Audit of Cancer Diagnosis in Primary Care. 2011, London: Royal College of General Practitioners, [http://www.rcgp.org.uk/news/2011/november/~/media/Files/News/National_Audit_of_Cancer_Diagnosis_in_Primary-Care.ashx].
18. Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, Patras J, Mahony BS, Andersen MR. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 2007, 109:221-227. 10.1002/cncr.22371, 17154394.
19. Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Dresher CW, Paley P, Urban N. Combining a symptoms index with CA 125 to improve detection of ovarian cancer. Cancer 2008, 113:484-489. 10.1002/cncr.23577, 2734274, 18615684.
20. Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Dresher CW, Paley P, Urban N. Use of a Symptom Index, CA125 and HE4 to predict ovarian cancer. Gynecol Oncol 2010, 116:378-383. 10.1016/j.ygyno.2009.10.087, 2822097, 19945742.
21. Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, Lewis S, Davies S, Philpott S, Lopes A, Godfrey K, Oram D, Herod J, Williamson K, Seif MW, Scott I, Mould T, Woolas R, Murdoch J, Dobbs S, Amso NN, Leeson S, Cruickshank D, McGuire A, Campbell S, Fallowfield L, Singh N, Dawnay A, Skates SJ, Parmar M, Jacobs I. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009, 10:327-340. 10.1016/S1470-2045(09)70026-9, 19282241.
22. Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet 1999, 353:1127-1131. 10.1016/S0140-6736(99)02142-X, 10209975.
23. Grunfeld E, Ramirez A, Hunter M, Richards M. Women's knowledge and beliefs regarding breast cancer. Brit J Cancer 2002, 86:1373-1378. 10.1038/sj.bjc.6600260, 2375381, 11986766.
24. Burgess CC, Ramirez A, Richards M, Love S. Who and what influences delayed presentation in breast cancer?. Brit J Cancer 1998, 77:1343-1348. 10.1038/bjc.1998.224, 2150175, 9579844.
25. Macleod U, Mitchell ED, Burgess C, Macdonald S, Ramirez AJ. Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Brit J Cancer 2009, 101:92-101.
26. Smith LK, Pope C, Botha JL. Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 2005, 366:825-831. 10.1016/S0140-6736(05)67030-4, 16139657.
27. Brouha XD, Tromp DM, Hordijk GJ, Winnubst JA, de Leeuw JR. Oral and pharyngeal cancer: analysis of patient delay at different tumor stages. Head Neck 2005, 27:939-945. 10.1002/hed.20270, 16206281.
28. Cancer in Wales 1995-2009: a comprehensive report. 2011, Welsh Cancer Intelligence and Surveillance Unit, [http://www.wales.nhs.uk/sites3/Documents/242/8%20Gynaecological%20Cancers.pdf].
29. Becker MH. The health belief model and sick role behavior. Health Educ Monogr 1974, 2:409-419.
30. Bandura A. Self-efficacy: The Exercise of Control 1997, New York: Freeman.
31. Rosenstock IM, Strecher VJ, Becker HM. Social learning theory and the health belief model. Health Educ Q 1988, 15:175-183. 10.1177/109019818801500203, 3378902.
32. Hay JL, McCaul KD, Magnan RE. Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence. Prev Med 2006, 42:401-408. 10.1016/j.ypmed.2006.03.002, 16626796.
33. Forbes LJL, Simon AE, Warburton F, Boniface D, Brain KE, Dessaix A, Donnelly C, Haynes K, Hvidberg L, Lagerlund M, Lockwood G, Tishelman C, Vedsted P, Vigmostad MN, Ramirez AJ, Wardle J, . International Cancer Benchmarking Partnership Module 2 Working Group, International Cancer Benchmarking Partnership Programme Board, International Cancer Benchmarking Partnership Module 2 Academic Reference Group Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the international cancer benchmarking partnership): do they contribute to differences in cancer survival?. Brit J Cancer 2013, 108:292-300. 10.1038/bjc.2012.542, 3566814, 23370208, International Cancer Benchmarking Partnership Module 2 Working Group, International Cancer Benchmarking Partnership Programme Board, International Cancer Benchmarking Partnership Module 2 Academic Reference Group.
34. Rizzo L, Brick JM, Park I. A minimally intrusive method for sampling persons in random digit dial surveys. Public Opin Q 2004, 68:267-274.
35. Simon AE, Forbes LJL, Boniface D, Warburton F, Brain KE, Dessaix A, Donnelly M, Hayne K, Hvidberg L, Lagerlund M, Peterman L, Tishelman C, Vedsted P, Vigmostad MN, Wardle J, Ramirez AJ, . ICBP Module 2 Working Group, ICBP Programme Board and Academic Reference Group An international measure of awareness and beliefs about cancer: development and testing of the ABC. BMJ Open 2012, 2:e001758. doi:10.1136/bmjopen-2012-001758, 3547316, 23253874, ICBP Module 2 Working Group, ICBP Programme Board and Academic Reference Group.
36. Stubbings S, Robb K, Waller J, Ramirez A, Austoker J, Macleod U, Hiom S, Wardle J. Development of a measurement tool to assess public awareness of cancer. Brit J Cancer 2009, 101:s13-s17. 2790699, 19956157.
37. Simon AE, Wardle J, Grimmett C, Power E, Corker E, Menon U, Matheson L, Waller J. Ovarian and cervical cancer awareness: development of two validated measurement tools. J Fam Plann Reprod Health Care 2012, 38:167-174. 10.1136/jfprhc-2011-100118, 21933805.
38. Cancer research UK " Be clear on cancer" campaign. [http://www.cancerresearchuk.org/cancer-info/spotcancerearly/naedi/beclearoncancer/ovarian/].
39. Tyndel S, Henderson B, Austoker J, Brain K, Bankhead C, Clements A, Watson E. What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS management group. J Clin Oncol 2007, 25:3823-3830. 10.1200/JCO.2007.11.0437, 17761970.
40. Andersen MR, Drescher CW, Zheng Y, Bowen DJ, Wilson S, Young A, McIntosh M, Mahony BS, Lowe KA, Urban N. Changes in cancer worry associated with participation in ovarian cancer screening. Psycho-Oncol 2007, 16:814-820.
41. AAPOR Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys 2011, The American Association of Public Opinion Research, 7, http://www.aapor.org/AM/Template.cfm?Section=Standard_Definitions2&Template=/CM/ContentDisplay.cfm&ContentID=3156, AAPOR.
42. Scott SE, Grunfeld EA, Auyeung V. Barriers and triggers to seeking help for potentially malignant oral symptoms: implications for interventions. Amer Assoc Publ Health Dentistry 2009, 69:34-40.
43. Low EL, Waller J, Menon U, Jones A, Reid F, Simon AE. Ovarian cancer symptom awareness and anticipated time to help-seeking for symptoms among UK women. J Fam Plann Reprod Health Care 2013, 39:163-171. 10.1136/jfprhc-2012-100473, 23709609.
44. Gollwitzer PM. Goal achievement: the role of intentions. Eur Rev Soc Psychol 1993, 4:141-185.
45. Neal RD. Do diagnostic delays in cancer matter?. Brit J Cancer 2009, 101:S9-S12. 2790696, 19956171.
46. Evans J, Ziebland S, McPherson A. Minimizing delays in ovarian cancer diagnosis: an expansion of Anderson's model of 'total patient delay'. Fam Prac 2006, 24:48-55.
47. Andersen MR, Smith R, Meischke H, Bowen D, Urban N. Breast cancer worry and mammography use by women with and without a family history in a population-based sample. Cancer Epid, Bio Prev 2003, 12:314-320.
48. Sheeran P. Intention-behaviour relations: a conceptual and empirical review. Eur Rev Soc Psychol 2002, 12:1-36.
49. Andersen RS, Vedsted P, Olesen F, Bro F, Søndergaard J. Patient delay in cancer studies: a discussion of methods and measures. BMC Health Serv Res 2009, 9:189. 10.1186/1472-6963-9-189, 2770466, 19840368.
50. Simon AE, Waller J, Robb K, Wardle J. Patent delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a population sample from the United Kingdom. Cancer Epid, Bio Prev 2010, 19:2272-2277.
51. Quaife S, Forbes L, Ramirez A, Brain KE, Donnelly C, Simon AE, Wardle J. Recognition of cancer warning signs and anticipated delay in help-seeking in a population sample of adults in the UK. Brit J Cancer 2013, 10.1038/bjc.2013.684.